Here we go again. With Aduhelm largely sidelined, Biogen and Eisai are hoping for a better fortunes with their next Alzheimer's disease therapy lecanemab, which is now fully filed with the FDA.

At the NFL Scouting Combine last month, Panthers general manager Dan Morgan wasn’t shy about his desire to bring back tight end Tommy Tremble. And it didn’t take long for the executive to get ...

SEOUL, South Korea (AP) — South Korea’s impeached conservative President Yoon Suk Yeol was released from prison on Saturday, a day after a Seoul court canceled his arrest to allow him to stand ...

CHARLOTTE — The Carolina Youth Coalition, a local nonprofit, is looking for mentors for high school students. They’re holding a campaign called “100 Heroes in 100 Days” to help students ...

SEOUL, South Korea — A South Korean court ruled Friday that the detention of impeached President Yoon Suk Yeol was unjustified, paving the way for his release from custody even as he faces trial ...

Researchers from the Drug Safety Research Unit are calling for the robust monitoring of the safety of lecanemab, a promising new drug to treat Alzheimer’s Disease (AD). In a review article, published ...

The National Institute for Health and Care Excellence (NICE) has decided to reconsult on draft guidance for Alzheimer’s treatments donanemab and lecanemab, six months after initially rejecting the ...

Associations between biomarkers of poor synapse health and higher levels of Alzheimer’s-related proteins in the brain, as well as steeper… The U.S. Food and Drug Administration (FDA) has approved ...

We respond to the disappointing decision NICE has made to not recommend donanemab and lecanemab on the NHS. On Thursday, 6 March, NICE published further draft guidance for public consultation that ...